A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
2021 · JID Innovations · 75 citations
https://doi.org/10.1016/j.xjidi.2021.100042
M
Masahiro Kamata
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
256
Papers
3.4K
Citations
31
h-index
72
i10-index
Masahiro Kamata is an academic researcher from Teikyo University. The author has contributed to research in topics: Dermatology and Skin Diseases & Psoriasis: Treatment and Pathogenesis & Autoimmune Bullous Skin Diseases. The author has an h-index of 31, co-authored 218 publications.
ORCID: 0000-0003-0976-4982Papers by this author
worksCD19 Expression in B Cells Regulates Atopic Dermatitis in a Mouse Model
2013 · American Journal Of Pathology · 32 citations
https://doi.org/10.1016/j.ajpath.2013.02.042
Blood DNA virome associates with autoimmune diseases and COVID-19
2025 · Nature Genetics · 16 citations
https://doi.org/10.1038/s41588-024-02022-z
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
2025 · Dermatology and Therapy · 16 citations
https://doi.org/10.1007/s13555-025-01357-7
Drug fever caused by eutectic mixture of local anesthetic cream.
2011 · PubMed · 1 citations
[Problems in the dental treatment of a case of hemophilia A].
1986 · PubMed · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat